| Trial ID: | L7057 |
| Source ID: | NCT03761797
|
| Associated Drug: |
Tradiance® Combination Tablets Ap
|
| Title: |
A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT03761797/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: TRADIANCE® Combination Tablets AP|DRUG: TRADIANCE® Combination Tablets BP
|
| Outcome Measures: |
Primary: Number of Participants With Adverse Drug Reactions (ADRs), The number of participants with adverse drug reactions is reported., From first dose of study medication until last dose + 7 days, up to 102.1 weeks. |
|
| Sponsor/Collaborators: |
Sponsor: Boehringer Ingelheim | Collaborators: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1164
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2019-01-15
|
| Completion Date: |
2021-04-27
|
| Results First Posted: |
2023-01-23
|
| Last Update Posted: |
2023-01-23
|
| Locations: |
Nippon Boehringer Ingelheim Co., Ltd, Tokyo, 1416017, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT03761797
|
